Breaking News Instant updates and real-time market news.

EHTH

eHealth

$56.39

-8.97 (-13.72%)

, WLTW

Willis Towers Watson

$180.19

-0.99 (-0.55%)

10:44
04/17/19
04/17
10:44
04/17/19
10:44

eHealth pullback presents 'very attractive' entry point, says SunTrust

SunTrust analyst Tobey Sommer said he views the mid-teen percentage decline in eHealth (EHTH) shares amid worries about Medicare for all proposals as presenting a "very attractive" entry point, noting that applying the same multiple paid by Willis Towers Watson (WLTW) for Tranzact implies a $62 share price for eHealth. While eHealth has a lower EBITDA margin, its revenue is growing faster and it has exposure in the individual and small business markets as well as the main Medicare business. The analyst, who believes eHealth's multi-year top-line growth outlook is substantially superior to consensus forecasts, driven by superior Medicare growth, keeps a Buy rating on the shares.

EHTH

eHealth

$56.39

-8.97 (-13.72%)

WLTW

Willis Towers Watson

$180.19

-0.99 (-0.55%)

  • 17

    Apr

  • 19

    Apr

  • 25

    Apr

  • 01

    May

  • 20

    May

  • 28

    May

EHTH eHealth
$56.39

-8.97 (-13.72%)

03/14/19
CANT
03/14/19
NO CHANGE
CANT
Cantor says Health Insurance, eHealth concerns over House probe overblown
The House Committee on Energy & Commerce announced yesterday that they have requested information and documents from 12 distributors of short-term, limited duration insurance plans. The E&C Committee believes the companies selling these products discriminate against individuals with pre-existing conditions and mislead consumers about the nature of the coverage they are purchasing, Cantor Fitzgerald analyst Steven Halper tells investors in a research note. He points out that shares of Health Insurance Innovations (HIIQ) and eHealth (EHTH) traded sharply lower on the news. Health Insurance Innovations focuses mostly on short-term plans, while eHealth's exposure is quite small, says Halper. The analyst, however, believes concerns regarding the request for information are overblown, as any proposed legislative action would likely not pass the Senate and would almost certainly be vetoed by President Trump. Further, he reminds investors that Health Insurance Innovations recently closed out a 43-state review with virtually no impact on its businesses. He reiterates Overweight ratings on both stocks.
04/08/19
RBCM
04/08/19
NO CHANGE
RBCM
Outperform
eHealth guidance still 'looks conservative', says RBC Capital
RBC Capital analyst Frank Morgan kept his Outperform rating on eHealth (EHTH), stating that its valuation is supported by the $1.4B deal by WillisTowers Watson (WLTW) to acquire Tranzact which is also validating his bullish MA thesis. The analyst also notes that the stock has performed well in an otherwise "difficult healthcare tape", in part because of its "strong growth prospects in a niche not perceived as a problem with the healthcare system."
04/10/19
RHCO
04/10/19
NO CHANGE
Target $90
RHCO
Buy
eHealth price target raised to $90 from $75 at SunTrust
SunTrust analyst Tobey Sommer raised his price target on eHealth to $90 and kept his Buy rating to reflect expectations of a "competitive 2019 Medicare annual enrollment period" and its potential rebate rule changes that could drive premiums higher. The analyst adds that customer acquisition changes have also been "key to growth acceleration" and could improve further from current levels, anticipating eHealth management to potentially update its multi-year financial goals in an Investor Day on May 7th.
04/17/19
RHCO
04/17/19
NO CHANGE
RHCO
eHealth weakness a buying opportunity, says SunTrust
WLTW Willis Towers Watson
$180.19

-0.99 (-0.55%)

03/25/19
RHCO
03/25/19
NO CHANGE
Target $200
RHCO
Buy
Willis Towers Watson price target raised to $200 from $192 at SunTrust
SunTrust analyst Mark Hughes raised his price target on Willis Towers Watson to $200 and kept his Buy rating after its Analyst Day, saying the presentation supports his view of its completed post-merger integration that positions the company for "solid, profitable growth across the entire platform." The analyst cites the management's expectation of profitable growth and its improved focus on cost controls, adding that the company should perform well "regardless of the macro-economic environment" given the improvement in Human Capital & Benefits segment at the start of 2019.
04/02/19
SBSH
04/02/19
NO CHANGE
Target $200
SBSH
Buy
Willis Towers Watson price target raised to $200 from $192 at Citi
Citi analyst James Naklicki raised his price target for Willis Towers Watson to $200 from $192 saying he has a favorable view of the company's Tranzact acquisition. Tranzact is highly levered to the "rapidly growing" Medicare Advantage and Medicare Supplemental market, Naklicki tells investors in a research note. He keeps a Buy rating on Willis Towers Watson.
04/08/19
MKMP
04/08/19
NO CHANGE
Target $210
MKMP
Buy
Willis Towers Watson price target raised to $210 from $190 at MKM Partners
MKM Partners analyst Harry Fong raised his price target on Willis Towers Watson to $210and kept his Buy rating after its latest TRANZACT acquisition, saying the deal positions the company for two new Health Reimbursement Arrangements to be launched in the next two years. The analyst notes that TRANZACT will "enhance Willis's capabilities in the direct-to-consumer channel with Medicare and other products", complementing the company's Liazon and Extend Health units facilitating transition from group health plan due to retirement into a Medicare plan. Fong also states that while Medicare business grows at a low single-digit rate, the potential growth rate for the individual HRA business could be "significantly higher."

TODAY'S FREE FLY STORIES

ADTN

Adtran

$17.39

-0.38 (-2.14%)

13:40
04/25/19
04/25
13:40
04/25/19
13:40
Earnings
Adtran VP Roger Shannon sold over $100K in company shares »

Adtran VP Roger Shannon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

AVYA

Avaya

$20.22

0.895 (4.63%)

13:34
04/25/19
04/25
13:34
04/25/19
13:34
Periodicals
Mitel offering to combine with Avaya in stock deal worth over $2B, WSJ says »

Avaya is in talks to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

TECK.B

Teck Corp.

$0.00

(0.00%)

13:34
04/25/19
04/25
13:34
04/25/19
13:34
Conference/Events
Teck Corp. management to meet with B.Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

CWT

California Water Service

$49.43

-0.57 (-1.14%)

13:32
04/25/19
04/25
13:32
04/25/19
13:32
Upgrade
California Water Service rating change  »

California Water Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

BHC

Bausch Health

$23.18

0.16 (0.70%)

13:30
04/25/19
04/25
13:30
04/25/19
13:30
Hot Stocks
Breaking Hot Stocks news story on Bausch Health »

Bausch Health trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

AVYA

Avaya

$20.20

0.875 (4.53%)

13:28
04/25/19
04/25
13:28
04/25/19
13:28
Periodicals
Mitel offers to combine with Avaya in stock deal, WSJ says »

Mitel's bid values…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

CLVS

Clovis

$19.43

-0.4 (-2.02%)

13:25
04/25/19
04/25
13:25
04/25/19
13:25
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 31

    May

AGN

Allergan

$140.66

0.98 (0.70%)

, TEVA

Teva

$15.07

0.065 (0.43%)

13:25
04/25/19
04/25
13:25
04/25/19
13:25
Conference/Events
Piper Jaffray specialty pharma analysts to hold analyst/industry conference call »

Specialty Pharmaceuticals…

AGN

Allergan

$140.66

0.98 (0.70%)

TEVA

Teva

$15.07

0.065 (0.43%)

ALDR

Alder Biopharmaceuticals

$13.95

0.29 (2.12%)

AMGN

Amgen

$179.82

1.56 (0.88%)

BHVN

Biohaven Pharmaceutical

$62.30

-0.855 (-1.35%)

LLY

Eli Lilly

$117.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

  • 21

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

ZM

Zoom Video

$64.49

1.175 (1.86%)

13:21
04/25/19
04/25
13:21
04/25/19
13:21
Hot Stocks
Zoom, Slack announce new partnership »

Zoom and Slack have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$23.18

0.16 (0.70%)

13:21
04/25/19
04/25
13:21
04/25/19
13:21
Hot Stocks
Bausch Health announces FDA approval of Duobrii for plaque psoriasis »

Bausch Health and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
04/25/19
04/25
13:17
04/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
04/25/19
04/25
13:16
04/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$382.62

7.3 (1.95%)

13:16
04/25/19
04/25
13:16
04/25/19
13:16
Recommendations
Boeing analyst commentary at Bernstein »

Bernstein says Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    May

  • 05

    Jun

BA

Boeing

$382.62

7.3 (1.95%)

13:15
04/25/19
04/25
13:15
04/25/19
13:15
Periodicals
FAA targeting May 23 for meeting over 737 MAX changes, Aviation Week says »

The FAA is targeting May…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    May

  • 05

    Jun

13:12
04/25/19
04/25
13:12
04/25/19
13:12
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:12
04/25/19
04/25
13:12
04/25/19
13:12
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

RSG

Republic Services

$79.29

-0.01 (-0.01%)

13:10
04/25/19
04/25
13:10
04/25/19
13:10
Options
Upside call buys in Republic Services ahead of earnings »

Upside call buys in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    May

  • 17

    May

  • 05

    Jun

LUV

Southwest

$54.00

1.08 (2.04%)

13:06
04/25/19
04/25
13:06
04/25/19
13:06
Hot Stocks
Breaking Hot Stocks news story on Southwest »

Southwest continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 21

    May

  • 13

    Nov

LUV

Southwest

$54.00

1.08 (2.04%)

, BA

Boeing

$379.25

3.93 (1.05%)

13:06
04/25/19
04/25
13:06
04/25/19
13:06
Hot Stocks
Southwest expects FY19 capacity to increase 2%-3% y-o-y »

Says continues to have…

LUV

Southwest

$54.00

1.08 (2.04%)

BA

Boeing

$379.25

3.93 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 15

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 13

    Nov

BUD

AB InBev

$86.38

-1.82 (-2.06%)

13:05
04/25/19
04/25
13:05
04/25/19
13:05
Options
Anheuser Busch call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

13:05
04/25/19
04/25
13:05
04/25/19
13:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

APD

Air Products

$199.33

-0.17 (-0.09%)

, PKX

Posco

$55.45

-0.75 (-1.33%)

13:02
04/25/19
04/25
13:02
04/25/19
13:02
Hot Stocks
Air Products to supply Posco's cathode material manufacturing site in Gwangyang »

Air Products (APD)…

APD

Air Products

$199.33

-0.17 (-0.09%)

PKX

Posco

$55.45

-0.75 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUV

Southwest

$54.18

1.26 (2.38%)

13:02
04/25/19
04/25
13:02
04/25/19
13:02
Hot Stocks
Southwest expects Q2 economic fuel costs $2.10-$2.20 per gallon »

Says continues to expect…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 21

    May

  • 13

    Nov

13:00
04/25/19
04/25
13:00
04/25/19
13:00
General news
Treasury $32 B 7-year auction preview: »

Treasury $32 B 7-year…

BDRBF

Bombardier

$0.00

(0.00%)

12:59
04/25/19
04/25
12:59
04/25/19
12:59
Downgrade
Bombardier rating change at Scotiabank »

Bombardier downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.